Global Health Limited (Medanta) has submitted a regulatory intimation to both BSE Limited and National Stock Exchange of India Limited regarding a scheduled meeting between the company's management and investors/analysts.

The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

  • Date of Meeting: November 23, 2026
  • Investor/Analyst Firm: Alquity Investment Management Ltd.
  • Type of Meeting: One to One
  • Place of Meeting: Gurugram
  • Mode of Meeting: In person

The company specifically notes that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during this meeting.

Important Note

The disclosure includes a note that the meeting is subject to change in case of any unforeseen circumstances on the part of either the analysts/investors or the company.